# Pharmacovigilance and Adverse Drug Reactions **Type:** Topics **Canonical URL:** https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/ ## Facts | Field | Value | | --- | --- | | Description | This cluster of papers focuses on the study, detection, monitoring, and reporting of adverse drug reactions (ADRs) through pharmacovigilance. It covers various aspects such as signal detection, drug safety surveillance, data mining techniques, patient reporting, regulatory actions, causality assessment, and the impact of ADRs on hospital admissions. | | Domain | Life Sciences | | Field | Pharmacology, Toxicology and Pharmaceutics | | OpenAlex ID | t11943 | | Works | 138 | ## Topic papers all Showing 15 of 138. - [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/) - [The Danish National Prescription Registry](https://scholariq.org/papers/the-danish-national-prescription-registry/) - [A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions](https://scholariq.org/papers/a-comparison-of-measures-of-disproportionality-for-signal-detection-in/) - [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid-2/) - [The reporting odds ratio and its advantages over the proportional reporting ratio](https://scholariq.org/papers/the-reporting-odds-ratio-and-its-advantages-over-the-proportional-reporting/) - [Adverse effects of biologics: a network meta-analysis and Cochrane overview](https://scholariq.org/papers/adverse-effects-of-biologics-a-network-meta-analysis-and-cochrane-overview/) - [Impact of covert duplicate publication on meta-analysis: a case study](https://scholariq.org/papers/impact-of-covert-duplicate-publication-on-meta-analysis-a-case-study/) - [The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)](https://scholariq.org/papers/the-reporting-of-studies-conducted-using-observational-routinely-collected-2/) - [Adverse drug events in hospitalized patients](https://scholariq.org/papers/adverse-drug-events-in-hospitalized-patients/) - [Adverse drug events and medication errors: detection and classification methods](https://scholariq.org/papers/adverse-drug-events-and-medication-errors-detection-and-classification-methods/) - [Nonadherence to antiepileptic drugs and increased mortality](https://scholariq.org/papers/nonadherence-to-antiepileptic-drugs-and-increased-mortality/) - [Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients](https://scholariq.org/papers/risk-of-death-associated-with-the-use-of-conventional-versus-atypical/) - [Drug allergies documented in electronic health records of a large healthcare system](https://scholariq.org/papers/drug-allergies-documented-in-electronic-health-records-of-a-large-healthcare/) - [Common Risk Allele in Aromatic Antiepileptic-Drug Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Han Chinese](https://scholariq.org/papers/common-risk-allele-in-aromatic-antiepileptic-drug-induced-stevens-johnson/) - [Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity](https://scholariq.org/papers/cost-effectiveness-analysis-of-hla-b-5701-genotyping-in-preventing-abacavir/) ## Topic primary papers Showing 15 of 34. - [The Danish National Prescription Registry](https://scholariq.org/papers/the-danish-national-prescription-registry/) - [A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions](https://scholariq.org/papers/a-comparison-of-measures-of-disproportionality-for-signal-detection-in/) - [The reporting odds ratio and its advantages over the proportional reporting ratio](https://scholariq.org/papers/the-reporting-odds-ratio-and-its-advantages-over-the-proportional-reporting/) - [Adverse drug events in hospitalized patients](https://scholariq.org/papers/adverse-drug-events-in-hospitalized-patients/) - [Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database](https://scholariq.org/papers/adverse-events-associated-with-jak-inhibitors-in-126-815-reports-from-the-who/) - [Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‐analysis](https://scholariq.org/papers/frequency-of-adverse-drug-reactions-in-hospitalized-patients-a-systematic-review/) - [Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study](https://scholariq.org/papers/adverse-drug-reactions-in-hospitalized-patients-results-of-the-forward/) - [The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database](https://scholariq.org/papers/the-drugs-that-mostly-frequently-induce-acute-kidney-injury-a-case-noncase-study/) - [Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process](https://scholariq.org/papers/pharmacist-s-knowledge-practice-and-attitudes-toward-pharmacovigilance-and/) - [Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features](https://scholariq.org/papers/adverse-drug-reactions-leading-to-urgent-hospital-admission-in-an-elderly/) - [Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study](https://scholariq.org/papers/prevalence-and-characteristics-of-adverse-drug-reactions-at-admission-to/) - [Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting](https://scholariq.org/papers/pharmacovigilance-pharmacists-and-amp-rsquo-perspective-on-spontaneous-adverse/) - [Pharmacoepidemiology in Japan: medical databases and research achievements](https://scholariq.org/papers/pharmacoepidemiology-in-japan-medical-databases-and-research-achievements/) - [Establishment of the MID‐NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan](https://scholariq.org/papers/establishment-of-the-mid-net-sup-sup-medical-information-database-network-as-a/) - [Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies](https://scholariq.org/papers/sequence-symmetry-analysis-in-pharmacovigilance-and-pharmacoepidemiologic/) --- Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.